vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $111.5M, roughly 1.4× AVIAT NETWORKS, INC.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 5.1%, a 2.7% gap on every dollar of revenue. On growth, AVIAT NETWORKS, INC. posted the faster year-over-year revenue change (-5.7% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $22.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 0.3%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
AVNW vs NUTX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $111.5M | $151.7M |
| Net Profit | $5.7M | $11.8M |
| Gross Margin | 32.4% | 30.4% |
| Operating Margin | 6.5% | 20.4% |
| Net Margin | 5.1% | 7.8% |
| Revenue YoY | -5.7% | -41.1% |
| Net Profit YoY | 27.2% | -80.8% |
| EPS (diluted) | $0.44 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $151.7M | ||
| Q3 25 | $107.3M | $267.8M | ||
| Q2 25 | $115.3M | $244.0M | ||
| Q1 25 | $112.6M | $211.8M | ||
| Q4 24 | $118.2M | $257.6M | ||
| Q3 24 | $88.4M | $78.8M | ||
| Q2 24 | $116.7M | $76.1M | ||
| Q1 24 | $110.8M | $67.5M |
| Q4 25 | $5.7M | $11.8M | ||
| Q3 25 | $162.0K | $55.4M | ||
| Q2 25 | $5.2M | $-17.7M | ||
| Q1 25 | $3.5M | $21.2M | ||
| Q4 24 | $4.5M | $61.6M | ||
| Q3 24 | $-11.9M | $-8.8M | ||
| Q2 24 | $1.5M | $-364.0K | ||
| Q1 24 | $3.9M | $-364.0K |
| Q4 25 | 32.4% | 30.4% | ||
| Q3 25 | 33.2% | 57.8% | ||
| Q2 25 | 34.2% | 51.2% | ||
| Q1 25 | 34.9% | 55.9% | ||
| Q4 24 | 34.6% | 55.0% | ||
| Q3 24 | 22.4% | 27.8% | ||
| Q2 24 | 35.3% | 29.7% | ||
| Q1 24 | 32.5% | 15.1% |
| Q4 25 | 6.5% | 20.4% | ||
| Q3 25 | 4.8% | 48.7% | ||
| Q2 25 | 7.7% | 13.8% | ||
| Q1 25 | 8.3% | 38.1% | ||
| Q4 24 | 6.7% | 44.4% | ||
| Q3 24 | -17.6% | 12.3% | ||
| Q2 24 | 4.7% | 7.0% | ||
| Q1 24 | 5.1% | 2.1% |
| Q4 25 | 5.1% | 7.8% | ||
| Q3 25 | 0.2% | 20.7% | ||
| Q2 25 | 4.5% | -7.3% | ||
| Q1 25 | 3.1% | 10.0% | ||
| Q4 24 | 3.8% | 23.9% | ||
| Q3 24 | -13.4% | -11.2% | ||
| Q2 24 | 1.3% | -0.5% | ||
| Q1 24 | 3.5% | -0.5% |
| Q4 25 | $0.44 | $2.34 | ||
| Q3 25 | $0.01 | $7.76 | ||
| Q2 25 | $0.42 | $-2.95 | ||
| Q1 25 | $0.27 | $3.33 | ||
| Q4 24 | $0.35 | $11.56 | ||
| Q3 24 | $-0.94 | $-1.72 | ||
| Q2 24 | $0.11 | $-0.07 | ||
| Q1 24 | $0.30 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $185.6M |
| Total DebtLower is stronger | $105.4M | — |
| Stockholders' EquityBook value | $271.6M | $329.4M |
| Total Assets | $659.4M | $918.5M |
| Debt / EquityLower = less leverage | 0.39× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $185.6M | ||
| Q3 25 | $64.8M | $166.0M | ||
| Q2 25 | $59.7M | $96.7M | ||
| Q1 25 | $49.4M | $84.7M | ||
| Q4 24 | $52.6M | $40.6M | ||
| Q3 24 | $51.0M | $46.9M | ||
| Q2 24 | $64.6M | $40.8M | ||
| Q1 24 | $59.2M | $30.0M |
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $87.6M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $74.9M | — | ||
| Q3 24 | $83.4M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $271.6M | $329.4M | ||
| Q3 25 | $263.6M | $317.2M | ||
| Q2 25 | $263.2M | $235.3M | ||
| Q1 25 | $256.1M | $176.9M | ||
| Q4 24 | $249.6M | $132.4M | ||
| Q3 24 | $247.1M | $60.4M | ||
| Q2 24 | $255.9M | $62.7M | ||
| Q1 24 | $256.0M | $63.0M |
| Q4 25 | $659.4M | $918.5M | ||
| Q3 25 | $643.3M | $964.5M | ||
| Q2 25 | $633.3M | $841.0M | ||
| Q1 25 | $628.3M | $761.9M | ||
| Q4 24 | $594.1M | $655.3M | ||
| Q3 24 | $590.9M | $438.5M | ||
| Q2 24 | $535.2M | $422.4M | ||
| Q1 24 | $490.3M | $404.3M |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $70.4M |
| Free Cash FlowOCF − Capex | $22.5M | $69.0M |
| FCF MarginFCF / Revenue | 20.2% | 45.5% |
| Capex IntensityCapex / Revenue | 1.3% | 0.9% |
| Cash ConversionOCF / Net Profit | 4.18× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $70.4M | ||
| Q3 25 | $-11.7M | $99.5M | ||
| Q2 25 | $10.5M | $27.3M | ||
| Q1 25 | $1.6M | $51.0M | ||
| Q4 24 | $20.8M | $54.0K | ||
| Q3 24 | $-27.2M | $6.8M | ||
| Q2 24 | $8.3M | $13.3M | ||
| Q1 24 | $15.3M | $3.1M |
| Q4 25 | $22.5M | $69.0M | ||
| Q3 25 | $-13.5M | $99.2M | ||
| Q2 25 | $8.2M | $26.5M | ||
| Q1 25 | $-1.2M | $50.9M | ||
| Q4 24 | $18.3M | $-341.0K | ||
| Q3 24 | $-32.6M | $6.2M | ||
| Q2 24 | $7.5M | $12.7M | ||
| Q1 24 | $14.8M | $2.3M |
| Q4 25 | 20.2% | 45.5% | ||
| Q3 25 | -12.6% | 37.0% | ||
| Q2 25 | 7.1% | 10.9% | ||
| Q1 25 | -1.0% | 24.0% | ||
| Q4 24 | 15.5% | -0.1% | ||
| Q3 24 | -36.8% | 7.8% | ||
| Q2 24 | 6.4% | 16.7% | ||
| Q1 24 | 13.4% | 3.4% |
| Q4 25 | 1.3% | 0.9% | ||
| Q3 25 | 1.6% | 0.1% | ||
| Q2 25 | 2.0% | 0.3% | ||
| Q1 25 | 2.5% | 0.0% | ||
| Q4 24 | 2.1% | 0.2% | ||
| Q3 24 | 6.1% | 0.8% | ||
| Q2 24 | 0.7% | 0.7% | ||
| Q1 24 | 0.4% | 1.1% |
| Q4 25 | 4.18× | 5.95× | ||
| Q3 25 | -72.48× | 1.80× | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | 2.40× | ||
| Q4 24 | 4.62× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
